GSK logo

GSK (GSK) Income tax

annual income tax:

$672.25M-$268.46M(-28.54%)
December 31, 2024

Summary

  • As of today (May 21, 2025), GSK annual income tax is $672.25 million, with the most recent change of -$268.46 million (-28.54%) on December 31, 2024.
  • During the last 3 years, GSK annual income tax has risen by +$558.06 million (+488.73%).
  • GSK annual income tax is now -84.88% below its all-time high of $4.45 billion, reached on December 31, 2007.

Performance

1-year change

-28.54%

3-year change

+488.73%

5-year change

-44.75%

15-year change

-61.6%

GSK Income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.59%
GSK annual income tax is higher than 97.59% of companies in Healthcare sector

Range

All-time high

$4.45B
GSK annual income tax is currently -84.88% below its historical high of $4.45 billion

3-year low

$114.19M
GSK annual income tax is currently +488.73% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
GSK previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
GSK next annual earnings announcement has not yet been scheduled

OtherGSKincome statement metrics

Annual total expenses

$34.96B
GSK annual total expenses is $34.96 billion

annual operating expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

annual cost of goods sold

$11.56B
GSK annual cost of goods sold is $11.56 billion

annual interest expense

$817.94M
GSK annual interest expense is $817.94 million

quarterly income tax:

$423.07M+$343.69M(+432.97%)
March 31, 2025

Summary

  • As of today (May 21, 2025), GSK quarterly income tax is $423.07 million, with the most recent change of +$343.69 million (+432.97%) on March 31, 2025.
  • Over the past year, GSK quarterly income tax has increased by +$75.53 million (+21.73%).
  • GSK quarterly income tax is now -85.19% below its all-time high of $2.86 billion, reached on March 31, 2015.

Performance

3-month change

+432.97%

1-year change

+21.73%

3-year change

-2.37%

5-year change

+111.59%

GSK quarterly income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.08%
GSK quarterly income tax is higher than 98.08% of companies in Healthcare sector

Range

All-time high

$2.86B
GSK quarterly income tax is currently -85.19% below its historical high of $2.86 billion

3-year low

-$23.60M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
GSK previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
GSK next earnings announcement is scheduled for Jul 30, 2025

OtherGSKincome statement metrics

Quarterly total expenses

$6.67B
GSK quarterly total expenses is $6.67 billion

quarterly operating expenses

$4.23B
GSK quarterly total operating expenses is $4.23 billion

quarterly cost of goods sold

$2.44B
GSK quarterly cost of goods sold is $2.44 billion

quarterly interest expense

$203.98M
GSK quarterly interest expense is $203.98 million

TTM income tax:

$742.13M+$75.53M(+11.33%)
March 31, 2025

Summary

  • As of today (May 21, 2025), GSK TTM income tax is $742.13 million, with the most recent change of +$75.53 million (+11.33%) on March 31, 2025.
  • Over the past year, GSK TTM income tax has dropped by -$210.14 million (-22.07%).
  • GSK TTM income tax is now -83.29% below its all-time high of $4.44 billion, reached on December 31, 2007.

Performance

3-month change

+11.33%

1-year change

-22.07%

3-year change

+122.28%

5-year change

-26.84%

GSK TTM income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.39%
GSK TTM income tax is higher than 97.39% of companies in Healthcare sector

Range

All-time high

$4.44B
GSK TTM income tax is currently -83.29% below its historical high of $4.44 billion

3-year low

$333.87M
GSK TTM income tax is currently +122.28% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
GSK previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 30, 2025
GSK next earnings announcement is scheduled for Jul 30, 2025

OtherGSKincome statement metrics

Annual total expenses

$34.96B
GSK annual total expenses is $34.96 billion

annual operating expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

TTM cost of goods sold

$11.51B
GSK TTM cost of goods sold is $11.51 billion

TTM interest expense

$810.87M
GSK TTM interest expense is $810.87 million

Income tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

GSK Income tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.5%+21.7%-22.1%
3 y3 years+488.7%-2.4%+122.3%
5 y5 years-44.8%+111.6%-26.8%

GSK Income tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-28.5%+488.7%-2.4%+1892.9%-23.1%+122.3%
5 y5-year-44.8%+681.8%-2.4%+160.4%-26.8%+336.0%
alltimeall time-84.9%+681.8%-85.2%+154.1%-83.3%+336.0%

GSK Income tax History

DateAnnualQuarterlyTTM
Mar 2025
-
$423.07M(+433.0%)
$742.13M(+11.3%)
Dec 2024
$672.25M(-28.5%)
$79.38M(-6200.5%)
$666.60M(+18.3%)
Sep 2024
-
-$1.30M(-100.5%)
$563.62M(-36.7%)
Jun 2024
-
$240.98M(-30.7%)
$890.35M(-6.5%)
Mar 2024
-
$347.54M(-1572.8%)
$952.27M(+1.3%)
Dec 2023
$940.71M(+7.4%)
-$23.60M(-107.3%)
$940.21M(-2.6%)
Sep 2023
-
$325.43M(+7.4%)
$964.99M(+5.6%)
Jun 2023
-
$302.90M(-9.7%)
$913.78M(+14.3%)
Mar 2023
-
$335.48M(>+9900.0%)
$799.45M(-10.9%)
Dec 2022
$875.50M(+666.7%)
$1.18M(-99.6%)
$897.33M(+21.5%)
Sep 2022
-
$274.22M(+45.4%)
$738.44M(-8.1%)
Jun 2022
-
$188.57M(-56.5%)
$803.39M(+140.6%)
Mar 2022
-
$433.36M(-374.8%)
$333.87M(+30.3%)
Dec 2021
$114.19M(+32.8%)
-$157.72M(-146.5%)
$256.16M(-189.3%)
Sep 2021
-
$339.18M(-220.7%)
-$286.74M(-8.8%)
Jun 2021
-
-$280.95M(-179.0%)
-$314.49M(-245.8%)
Mar 2021
-
$355.65M(-150.8%)
$215.72M(+259.4%)
Dec 2020
$85.99M(-92.9%)
-$700.62M(-325.0%)
$60.02M(-94.1%)
Sep 2020
-
$311.43M(+24.9%)
$1.01B(+2.2%)
Jun 2020
-
$249.26M(+24.7%)
$988.69M(-2.5%)
Mar 2020
-
$199.95M(-20.0%)
$1.01B(-16.7%)
Dec 2019
$1.22B(+21.0%)
$249.92M(-13.7%)
$1.22B(+14.5%)
Sep 2019
-
$289.56M(+5.3%)
$1.06B(+3.7%)
Jun 2019
-
$275.03M(-31.9%)
$1.03B(+9.1%)
Mar 2019
-
$403.85M(+324.2%)
$939.88M(-7.8%)
Dec 2018
$1.01B(-42.5%)
$95.20M(-62.1%)
$1.02B(-48.8%)
Sep 2018
-
$251.41M(+32.7%)
$1.99B(-7.5%)
Jun 2018
-
$189.42M(-60.9%)
$2.16B(+16.6%)
Mar 2018
-
$483.90M(-54.7%)
$1.85B(+4.5%)
Dec 2017
$1.75B(+47.3%)
$1.07B(+158.4%)
$1.77B(+112.6%)
Sep 2017
-
$413.65M(-451.7%)
$832.72M(-10.5%)
Jun 2017
-
-$117.61M(-129.0%)
$930.03M(-28.3%)
Mar 2017
-
$405.00M(+207.6%)
$1.30B(+9.0%)
Dec 2016
$1.19B(-63.9%)
$131.67M(-74.2%)
$1.19B(+10.5%)
Sep 2016
-
$510.96M(+104.4%)
$1.08B(+18.8%)
Jun 2016
-
$249.94M(-16.1%)
$906.80M(+27.1%)
Mar 2016
-
$297.76M(+1535.8%)
$713.54M(-78.2%)
Dec 2015
$3.29B(+1357.7%)
$18.20M(-94.7%)
$3.27B(+32.3%)
Sep 2015
-
$340.90M(+501.5%)
$2.47B(+2.9%)
Jun 2015
-
$56.67M(-98.0%)
$2.40B(-14.9%)
Mar 2015
-
$2.86B(-465.6%)
$2.83B(+935.0%)
Dec 2014
$225.83M(-85.8%)
-$781.49M(-387.2%)
$273.02M(-75.6%)
Sep 2014
-
$272.14M(-43.1%)
$1.12B(-23.0%)
Jun 2014
-
$477.94M(+57.0%)
$1.46B(+12.7%)
Mar 2014
-
$304.44M(+358.7%)
$1.29B(-18.3%)
Dec 2013
$1.59B(-47.7%)
$66.37M(-89.1%)
$1.58B(-46.7%)
Sep 2013
-
$607.85M(+94.0%)
$2.97B(+4.3%)
Jun 2013
-
$313.35M(-47.2%)
$2.85B(-1.5%)
Mar 2013
-
$593.39M(-59.2%)
$2.89B(-5.4%)
Dec 2012
$3.05B(-15.2%)
$1.45B(+198.7%)
$3.06B(+35.3%)
Sep 2012
-
$486.33M(+35.9%)
$2.26B(-12.3%)
Jun 2012
-
$357.76M(-52.8%)
$2.57B(-12.5%)
Mar 2012
-
$758.67M(+15.8%)
$2.94B(-18.1%)
Dec 2011
$3.59B(+78.7%)
$655.25M(-18.3%)
$3.59B(+12.8%)
Sep 2011
-
$801.87M(+10.5%)
$3.19B(+3.1%)
Jun 2011
-
$725.99M(-48.5%)
$3.09B(+19.1%)
Mar 2011
-
$1.41B(+468.4%)
$2.60B(+28.4%)
Dec 2010
$2.01B
$248.01M(-64.9%)
$2.02B(-25.8%)
Sep 2010
-
$706.37M(+205.7%)
$2.72B(-6.3%)
DateAnnualQuarterlyTTM
Jun 2010
-
$231.05M(-72.4%)
$2.91B(-19.5%)
Mar 2010
-
$835.81M(-12.1%)
$3.61B(+3.5%)
Dec 2009
$3.48B(-3.3%)
$950.69M(+6.9%)
$3.49B(+11.4%)
Sep 2009
-
$889.01M(-4.8%)
$3.13B(-1.6%)
Jun 2009
-
$933.70M(+30.7%)
$3.18B(-3.3%)
Mar 2009
-
$714.29M(+20.4%)
$3.29B(-9.8%)
Dec 2008
$3.60B(-19.0%)
$593.06M(-36.9%)
$3.65B(-12.0%)
Sep 2008
-
$939.57M(-9.9%)
$4.15B(-3.3%)
Jun 2008
-
$1.04B(-2.7%)
$4.29B(-0.7%)
Mar 2008
-
$1.07B(-1.8%)
$4.32B(-2.7%)
Dec 2007
$4.45B(+4.8%)
$1.09B(+0.8%)
$4.44B(+2.9%)
Sep 2007
-
$1.08B(+0.8%)
$4.32B(-0.8%)
Jun 2007
-
$1.07B(-9.9%)
$4.35B(+1.2%)
Mar 2007
-
$1.19B(+23.3%)
$4.30B(+1.7%)
Dec 2006
$4.24B(+21.7%)
$967.27M(-13.4%)
$4.23B(+4.3%)
Sep 2006
-
$1.12B(+9.0%)
$4.06B(+5.8%)
Jun 2006
-
$1.02B(-8.6%)
$3.83B(+4.0%)
Mar 2006
-
$1.12B(+41.1%)
$3.69B(+5.7%)
Dec 2005
$3.49B(+8.3%)
$794.31M(-11.2%)
$3.49B(-4.8%)
Sep 2005
-
$894.84M(+2.1%)
$3.67B(+4.6%)
Jun 2005
-
$876.40M(-5.0%)
$3.51B(+3.1%)
Mar 2005
-
$922.77M(-5.1%)
$3.40B(+5.5%)
Dec 2004
$3.22B(+13.4%)
$971.94M(+32.2%)
$3.22B(+16.0%)
Sep 2004
-
$735.21M(-4.5%)
$2.78B(+0.4%)
Jun 2004
-
$769.66M(+3.2%)
$2.77B(-2.7%)
Mar 2004
-
$745.84M(+41.5%)
$2.84B(+0.6%)
Dec 2003
$2.84B(+29.3%)
$527.21M(-27.2%)
$2.83B(-1.5%)
Sep 2003
-
$724.46M(-14.4%)
$2.87B(+10.7%)
Jun 2003
-
$846.61M(+16.0%)
$2.59B(+9.2%)
Mar 2003
-
$730.08M(+28.3%)
$2.38B(+8.6%)
Dec 2002
$2.20B(-7.6%)
$569.12M(+27.1%)
$2.19B(-14.0%)
Sep 2002
-
$447.76M(-28.8%)
$2.55B(+1.3%)
Jun 2002
-
$628.83M(+16.0%)
$2.51B(+2.5%)
Mar 2002
-
$542.01M(-41.5%)
$2.45B(+3.2%)
Dec 2001
$2.38B(-10.2%)
$926.52M(+122.9%)
$2.38B(-8.1%)
Sep 2001
-
$415.61M(-26.9%)
$2.59B(-0.7%)
Jun 2001
-
$568.39M(+22.0%)
$2.61B(+0.7%)
Mar 2001
-
$465.76M(-59.0%)
$2.59B(-1.2%)
Dec 2000
$2.65B(+119.4%)
$1.14B(+161.4%)
$2.62B(+76.7%)
Sep 2000
-
$434.65M(-20.9%)
$1.48B(+41.6%)
Jun 2000
-
$549.83M(+10.8%)
$1.05B(+28.7%)
Mar 2000
-
$496.12M(+56.6%)
$812.96M(+156.6%)
Dec 1999
$1.21B(-10.6%)
-
-
Jun 1999
-
$316.84M(+4.5%)
$316.84M(+4.5%)
Dec 1998
$1.35B(+0.7%)
-
-
Jun 1998
-
$303.26M
$303.26M
Dec 1997
$1.34B(-7.9%)
-
-
Dec 1996
$1.46B(+6.5%)
-
-
Dec 1995
$1.37B(+81.9%)
-
-
Jun 1995
$752.17M(-4.1%)
-
-
Jun 1994
$784.25M(+4.7%)
-
-
Jun 1993
$749.33M(+10.4%)
-
-
Jun 1992
$679.01M(+1.9%)
-
-
Jun 1991
$666.12M(+14.7%)
-
-
Jun 1990
$580.97M(+7.1%)
-
-
Jun 1989
$542.31M(+20.8%)
-
-
Jun 1988
$448.91M(+20.1%)
-
-
Jun 1987
$373.65M(+24.1%)
-
-
Jun 1986
$301.00M
-
-

FAQ

  • What is GSK annual income tax?
  • What is the all time high annual income tax for GSK?
  • What is GSK annual income tax year-on-year change?
  • What is GSK quarterly income tax?
  • What is the all time high quarterly income tax for GSK?
  • What is GSK quarterly income tax year-on-year change?
  • What is GSK TTM income tax?
  • What is the all time high TTM income tax for GSK?
  • What is GSK TTM income tax year-on-year change?

What is GSK annual income tax?

The current annual income tax of GSK is $672.25M

What is the all time high annual income tax for GSK?

GSK all-time high annual income tax is $4.45B

What is GSK annual income tax year-on-year change?

Over the past year, GSK annual income tax has changed by -$268.46M (-28.54%)

What is GSK quarterly income tax?

The current quarterly income tax of GSK is $423.07M

What is the all time high quarterly income tax for GSK?

GSK all-time high quarterly income tax is $2.86B

What is GSK quarterly income tax year-on-year change?

Over the past year, GSK quarterly income tax has changed by +$75.53M (+21.73%)

What is GSK TTM income tax?

The current TTM income tax of GSK is $742.13M

What is the all time high TTM income tax for GSK?

GSK all-time high TTM income tax is $4.44B

What is GSK TTM income tax year-on-year change?

Over the past year, GSK TTM income tax has changed by -$210.14M (-22.07%)
On this page